Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Biopharma Portfolio

Browse 23 Biopharma companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Biopharma Companies
23
Total Funding in Biopharma
$1.1B

Biopharma Portfolio Companies (23)

Export
BiopharmaBiotechnologyHealth CareLife ScienceOncologyPharmaceuticalPrecision Medicine

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

New York, United States
June 2023
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Watertown, United States
June 2026
$10.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Foster City, United States
September 2025
$63.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Woburn, United States
December 2025
$110.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Boston, United States
December 2023
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaClinical TrialsPharmaceutical

ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.

Wan Chai, Hong Kong
November 2022
$12.5M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

CSR Biotech is a biological research company that provides cell imaging and data processing services.

Haidian, China
March 2026
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedical

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Changping, China
March 2026
$72.8M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

Chengdu, China
January 2026
$86.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Brise Pharma operates in the scientific research and technical service industry.

Shanghai, China
November 2025
$28.1M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.

Tianjin, China
June 2025
$27.8M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Yuyao Bio is an innovative drug research and development company.

Shanghai, China
April 2025
$71.3M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

Chenzhang Bio is a biotechnology developer specializing in stem cell storage and treatment technology.

Chongqing, China
August 2024
$2.8M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareTherapeutics

Alpha Biophama is a clinical stage biopharmaceutical company.

Huangpu, China
June 2024
$23.9M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.

Pudong, China
November 2023
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Genevide is a biotech company that specializes in gene research and development.

Suzhou, China
September 2021
$6.0M
Angel

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

Shanghai, China
September 2020
$147.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceutical

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Shanghai, China
July 2020
$97.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalPrecision Medicine

Qiagen Suzhou Translational Medicine is a precision medicine solutions provider that provides pharmaceutical supply chain services.

Suzhou, China
July 2017
$25.7M
Series A

Founder Contacts

30,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio